Achmea Investment Management B.V. - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 390 filers reported holding SEATTLE GENETICS INC in Q1 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.

Quarter-by-quarter ownership
Achmea Investment Management B.V. ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q4 2019$729,000
+45.5%
6,384
-6.7%
0.03%
+33.3%
Q1 2019$501,000
+29.1%
6,8460.0%0.02%
+16.7%
Q4 2018$388,000
-26.4%
6,8460.0%0.02%
-10.0%
Q3 2018$527,000
+33.4%
6,846
+8.9%
0.02%
+5.3%
Q1 2017$395,0006,2870.02%
Other shareholders
SEATTLE GENETICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Baker Brothers Advisors 45,725,556$2,487,928,00020.18%
Lagoda Investment Management, L.P. 306,694$16,687,0006.03%
NEXTHERA CAPITAL LP 373,000$20,295,0005.22%
Redmile Group, LLC 1,843,733$100,318,0004.95%
Matrix Capital Management Company, LP 2,118,000$115,240,0003.68%
Sio Capital Management, LLC 100,000$5,441,0002.82%
Opus Point Partners Management, LLC 41,263$2,245,0002.01%
Eventide Asset Management 525,000$28,565,0001.62%
EMORY UNIVERSITY 35,982$1,958,0001.55%
Everett Capital Advisors UK LLP 191,500$10,420,0001.54%
View complete list of SEATTLE GENETICS INC shareholders